Trials / Completed
CompletedNCT00191529
Growth Hormone Treatment in Short Children Born Small for Gestational Age
Optimization of Growth Hormone Treatment in Short Children Born Small for Gestational Age Based on a Growth Prediction Model-The OPTIMA Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 200 (planned)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 3 Years
- Healthy volunteers
- Not accepted
Summary
Comparison of 2 different doses of human growth hormone treatment on change in height after 1 and 2 years of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | somatropin |
Timeline
- Start date
- 2002-12-01
- Completion
- 2007-06-01
- First posted
- 2005-09-19
- Last updated
- 2007-06-15
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00191529. Inclusion in this directory is not an endorsement.